Schedule 13G ownership disclosure
ORIC Pharmaceuticals Inc
Common Stock · CUSIP: 68622P109
Event date: 2025-07-29
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- EcoR1 Capital, LLC
Shares: 6,728,116.00 · Class: 6.9%
- Oleg Nodelman
Shares: 6,728,116.00 · Class: 6.9%
- EcoR1 Capital Fund Qualified, L.P.
Shares: 6,283,426.00 · Class: 6.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-25-000480
- Form type
- SCHEDULE 13G
- Filer
- EcoR1 Capital, LLC
- CIK
- CIK 1587114
- Filed
- Aug 05, 2025
- Reporting period
- Jul 29, 2025
- Description
- Schedule 13G beneficial ownership